Highlights
• According to filings registered with the Securities and Exchange Commission, Pfizer CEO sold 132,508 shares in the company at an average price of $41.94 per share, or $5.6 million
• The sale of this stock was carried through a routine 10b5-1 and now Bourla continues to own 81,812 shares in Pfizer
• Prior to sale, Bourla had announced that “The first set of results from our Phase 3....
Tags : Pfizer, Albert Bourla, COVID-19 vaccine, stocks, BioNTech, ,
comments (0)